Axodin 30 mg/5 ml (Oral Suspension)
50 ml bottle: ৳ 55.00
Medicine Details
Category | Details |
---|---|
Generic | Fexofenadine hydrochloride |
Company | Beximco pharmaceuticals ltd |
Also available as |
Chemical structure
- Molecular Formula: C32H39NO4
Therapeutic class
- Non-sedating antihistamines
Storage conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Dosage and administration
- Adults and children 12 years and older:
- Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily
- In case of impaired renal function: 60 mg once daily
- Children from 6 to 11 years:
- Tablet: 30 mg twice daily or 60 mg once daily
- In case of impaired renal function: 30 mg once daily
- Children from 2 to 11 years:
- Suspension: 30 mg or 5 ml twice daily
- In case of impaired renal function: 30 mg or 5 ml once daily
- Children from 6 months to less than 2 years:
- Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily
- In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily
Interactions
- Coadministration of Axodin with erythromycin or ketoconazole results in a 2-3 times increase in the level of fexofenadine in plasma
- No interaction between fexofenadine and omeprazole was observed
- Administering an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Axodin causes a reduction in bioavailability
Contraindications
- Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients
Side effects
- Headache
- Drowsiness
- Dizziness
- Nausea
- Fatigue
- Hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing, and systemic anaphylaxis
- Insomnia
- Nervousness
- Sleep disorders
- Tachycardia
- Palpitations
- Diarrhea
- Rash
- Urticaria
- Pruritus
Pregnancy and lactation
- Not recommended for use during pregnancy unless clearly necessary
- Not recommended for mothers breast-feeding their babies
Precautions and warnings
- Administered with care in older people and renally or hepatically impaired patients
- Patients with a history of or ongoing cardiovascular disease should be warned of the potential adverse reactions
Special populations
- The pharmacokinetics of fexofenadine are altered in individuals with renal impairment
- Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially
- Adverse events were similar in elderly patients compared to those under 65 years of age
- Increased bioavailability in individuals over 65 years of age
Overdose effects
- Dizziness
- Drowsiness
- Fatigue
- Dry mouth
- Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions
- Maximum tolerated dose has not been established
- Haemodialysis does not effectively remove Axodin from blood
Indications
- Relief of symptoms associated with seasonal and perennial allergic rhinitis in adults and children 12 years of age and over
- Relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and over
Pharmacology
- Fexofenadine is considered an "inverse agonist" of the H1 receptor
- Has a potent and selective affinity for H1 receptors
- Does not carry antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity
- Does not cross the blood-brain barrier
Use cases
- Allergic Rhinitis: Relief of symptoms including sneezing, rhinorrhea, lacrimation, itchy, red eyes, and itchy nose/palate/throat
- Chronic Idiopathic Urticaria: Relief of symptoms including signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus
Interaction details
- Erythromycin or ketoconazole coadministration: 2-3 times increase in fexofenadine level in plasma
- No interaction with omeprazole
- Antacid containing aluminium and magnesium hydroxide gels: Reduces bioavailability
Side effects details
- Headache
- Drowsiness
- Dizziness
- Nausea
- Fatigue
- Hypersensitivity reactions (e.g., angioedema, chest tightness, dyspnoea, flushing, systemic anaphylaxis)
- Insomnia
- Nervousness
- Sleep disorders or nightmares/excessive dreaming (paroniria)
- Tachycardia
- Palpitations
- Diarrhea
- Rash
- Urticaria
- Pruritus